FindTrial
Sign In

Point Of Care Test kit for Acute Myocardial Infarction.

In-house development and validation of nanoparticle-based Point of Care Test (POCT) device for early detection of acute myocardial infarctions.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/04/065153
Enrollment
200
Registered
2024-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I219- Acute myocardial infarction, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Science and Engineering Research Board
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients of acute MI presenting to the emergency

Exclusion criteria

Exclusion criteria: Patients who do not fall under the criteria of having Acute MI.

Design outcomes

Primary

MeasureTime frame
Development of POCT device (lateral flow assay system) using fatty acid binding protein-3 and troponin I as biomarkers for early detection of acute MI.Timepoint: First 6 months:1.Advertisement and appointment of Project staff 2.Tender and procurement of Equipment’s 3.Procurement of reagents and consumables. Next 6-12 months4.Design and Development of POCT 5.Clinical validation initiation with recruitment of subjects Next 6 months6.Clinical validation 7.Report preparation 8.Manuscript communication—

Secondary

MeasureTime frame
Clinical validation of the device as per WHO guidelines.Timepoint: 6 months clinical trials—

Countries

India

Contacts

Public ContactDr Binita Goswami

Maulana Azad Medical College

binita.dr@gmail.com9810592004

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026